ALFA Filings
Every announcement, straight from the exchange
Every Max Healthcare Institute employee stock options announcement on NSE and BSE, newest first, each with its own page.
Time
9 announcements with these filters
Max Healthcare Institute Limited has instituted the MHIL PRSU Scheme 2026. The scheme covers up to 73.50 lakh equity shares for employee stock-based incentives.
Max Healthcare Institute Limited has allotted 33,765 equity shares under its ESOP scheme. This increases the total paid-up share capital to 973,310,251 equity shares.
Max Healthcare allotted 33,765 equity shares under its Employee Stock Option Scheme 2022. The allotment was made at an exercise price of ₹350 per share.
Max Healthcare approved the grant of 3,61,827 stock options to eligible employees under its ESOP 2022 scheme. The grant is split into two tranches.
Max Healthcare allotted ESOP shares, increasing paid-up capital. No financial value disclosed; share count rose from 973.24 million to 973.27 million.
Max Healthcare allotted 29,649 shares under its ESOP 2022 scheme. The paid-up capital increased to ₹973.27 Crore post-allotment.
Max Healthcare granted 2,15,000 stock options worth ₹13.15 Crore to eligible employees. This employee incentive scheme aligns long-term staff interests with company performance and growth.
Max Healthcare Institute Limited allotted 51,287 equity shares on May 1, 2026, under its ESOP/ESPS scheme. This increases the company's total paid-up share capital from 973,192,502 to 973,243,789 shares. The allotment follows a 2022 board approval for employee stock-based benefits.
Max Healthcare Institute Limited allotted 51,287 equity shares to employees under its ESOP Scheme 2022 on May 1, 2026. The allotment, valued at ₹1.80 Crore based on an exercise price of ₹350 per share, increases the company's paid-up equity capital to ₹973.24 Crore.